Summary: Destruxin B, a peptide antibiotic, inhibits vacuolar-type ATPase (V-ATPase) specifically and dose-dependently among ATPases examined. Acidification of intracellular organelles is also blocked by destruxin B at comparable concentrations when assessed by accumulation of acridine orange. The inhibitory activity of destruxin B is weaker than that of bafilomycin Al and folimycin, well known macrolide inhibitors of V-ATPase, when compared at the same molar concentration. Unlike the macrolide antibiotics, however, the inhibitory activity of destruxin B is readily reversible. This novel feature of destruxin B should make it a useful probe in the analysis of V-ATPase function in cell physiology. S) 1994 Academic Press, Inc.
maintained by V-ATPase activity, specific V-ATPase inhibitors overcome some of the unavoidable drawbacks associated with other nonspecific drugs. Bafilomycins, 16-membered macrolides, were the first to be reported as specific inhibitors of V-ATPase (4) and have now being widely used.
In the course of searching for drugs capable of inhibiting the intracellular translocation of virus glycoproteins, folimycin (concanamycin A), an 18-membered macrolide antibiotic structurally related to the bafilomycins, was found to also be a specific inhibitor of V-ATPase and to possess ever more activity than bafilomycin Al (5, 6) . These two antibiotics exhibit a similar but distinct activity against protein secretion (7) indicating that the V-ATPase localized to different organelles has a distinct sensitivity to these inhibitors. Given the specific and distinct activities of these inhibitors against various V-ATPases, the possibility of obtaining inhibitors of still greater V-ATPase and organelle specificity become evident. We found that inhibitors of V-ATPase induce characteristic morphological changes among virus-infected cells (unpublished observation) and that these changes could be used to screen for V-ATPase inhibitors from many kinds of microorganisms isolated from various sources. Although concanamycins and bafilomycins are very specific and strong inhibitors of V-ATPases (5, 8) , the activity of these inhibitors is not readily reversed by washing as will be described in this report. To overcome this drawback, we have selected readily reversible inhibitors of V-ATPase from the above mentioned candidates. In this study we report that destruxin B, a peptide antibiotic (9) , is a specific inhibitor of V-ATPase among H+-translocating ATPases and that its action is readily reversible after a brief wash of treated cells. This unique characteristic should make it a useful addition to further studies on V-ATPase.
Materials and methods
Reagents: Destruxin B was obtained from a culture of an unidentified fungus isolated from a soil sample and its structure was confirmed by 1 H-NMR and mass spectrometry. Folimycin was purified from a culture of a Streptomyces (5), and bafilomycin A 1 was purchased from Wako Pure Chemical Industries (Osaka, Japan). Stock solutions of destruxin B (4x10-2 M), folimycin (1x10-3 M) and bafilomycin Al(1x10-3 M) were prepared in dimethylsulfoxide and stored at -20°C. Other chemicals of reagent grade were obtained as described previously.
ATPase activity: The procedures for assay of ATPase activity were the same as previously described (6) . Briefly, vacuole and mitochondria membranes were prepared from a culture of Saccharomyces cerevisiae during logarithmic growth and porcine cerebral cortex Na+,K+-ATPase was obtained from Sigma (St. Louis, MO). The membranes and ATPase were pretreated for 30 min at 30°C with the designated concentrations of inhibitors before initiating the enzymatic reaction with the addition of ATP, and ATPase activity was followed by quantitating inorganic phosphate liberated from ATP.
Acridine orange accumulation in acidic intracellular organelles: Cultures of BHK-21 cells in MEM supplemented with 10% calf serum were prepared on glass coverslips in 6-well plates (Corning). The acidity of intracellular organelles was assayed by examining the accumulation of acridine orange under a fluorescent microscope (Olympus, Tokyo) as reported previously (6) . Inhibition of acidification was determined after a 50-min treatment with the designated concentrations of inhibitors followed by a 10-min incorporation of acridine orange (5x10-6 M) in the presence of the inhibitors. Reversibility of the inhibition of acidification was tested after 50 min of treatment. BHK cells on glass coverslips were treated with inhibitors of the designated concentrations for 50 min, and the medium was removed by aspiration. After rinsing with phosphate buffered saline 5 times, the cells were incubated in pre-warmed fresh medium without inhibitor. After 20 min period to allow for cell recovery at 37°C, acridine orange was added and the intra-compartmental accumulation of the dye was examined as described above.
Cell growth: BHK cells were seeded in each well of 96-well plates, treated with designated 2-fold serially diluted concentrations of drugs, and incubated at 37°C in a humidified 5% CO2 -95% air incubator. Degrees of cell growth were determined colorimetrically using 2-(4-iodopheny1)-3-(4-nitropheny1)-5-(2,4-disulfopheny1)-2H-tetrazolium monosodium salt (Wako Pure Chemical Industries, Osaka) (10) according to the manufacturer's recommendations. Cell growth was determined daily for 3 days and duplicate samples were used for each determination.
Results

Destruxin B specifically inhibits V-ATPase in vitro
At the beginning of the present experiments, the purity of enzyme preparations used in this study was certified with the aid of drugs known to affect specific types of ATPase, i.e. Nethylmaleimide (an inhibitor of V-type ATPase), oligomycin (an inhibitor of F-type ATPase), and vanadate (an inhibitor of P-type ATPase) (1) . Based on the spectra of sensitivity for each ATPase to these inhibitors, we confirmed that only one specific type of ATPase activity was present in each preparation (data not shown).
The effect of destruxin B on ATPase activity over a broad range of concentration is shown in Fig. 1 . Yeast mitochondria ATPase and porcine cerebral cortex Na+,K-LATPase showed no sensitivity to destruxin B even at the highest concentration examined (2x10-4 M). Destruxin B inhibited V-ATPase dose dependently, and the enzyme activity was suppressed nearly completely at concentrations above 2x10-5 M. The 50% inhibition concentration (IC50) was 5.4x10-6 M. Fig. 1 shows dose response curves of the effect of folimycin and bafilomycin Al, specific inhibitors of V-ATPase, and their IC50's were calculated to be 4x10-9 M and 2x10-8 M, respectively. These observations indicate that destruxin B is a specific inhibitor of VATPase but that its action is not as strong as that of the 16-or 18-membered macrolide antibiotics at equi-molar concentration. 
Destruxin B inhibits the acidification of intracellular organelles of BHK cells
Since acridine orange accumulates in acidic intracellular compartments, the acidification of the lumen for these compartments can be easily followed by fluorescent microscopy (11, 12) .
BHK cells on glass coverslips were treated with the designated concentrations of destruxin B and processed for fluorescent microscopy as described in the "Materials and methods". The minimum time duration required for the disruption of acidification after the addition of destruxin B was not determined, but 1 h was enough to almost completely suppress the intracompartmental accumulation of acridine orange as shown in Fig. 2D . The dose dependency of inhibition by destruxin B is shown in Fig. 2A in comparison with that of folimycin and bafilomycin A 1. The minimum inhibitory concentration required for the suppression of acidification was similar to that for V-ATPase activity, indicating that destruxin B is similar to folimycin and bafilomycin Al in its effectiveness at the cellular and at the enzymatic level.
Inhibition of cell growth by destruxin B is correlated with the blockade of acidification
Destruxin B inhibitory activity was exhibited specifically against V-ATPase among the ATPases examined, but it is not known if the target of action of destruxin B is restricted solely to V-ATPase. To obtain some insight into this question, the effect of destruxin B on BHK cell
Concentration (MI Fig. 3 . Effects of destruxin B, folimycin and bafilomycin Al on the growth of BHK cells. BHK cells were implanted in 96-well plates, and the indicated concentrations of inhibitors were added at the start of experiments. Cell growth was examined every day for 3 days and is presented as third day growth expressed as % of the false-treated control.
•; destruxin B: o; folimycin and o; bafilomycin Al. growth was tested and compared to that of folimycin and bafilomycin A 1. The effect of destruxin B and the macrolide antibiotics on cell growth, as shown in Fig. 3 , is similar to that seen against V-ATPase in vitro and cellular acidification ( Fig. 1 and 2A ). This correlation among structurally unrelated drugs suggests that the blockade of acidification is a pivotal cause in the arrest of cell growth by destruxin B, but it does not rule out other possibilities.
Blockade of acidification in intracellular organelles by destruxin B is readily reversed
The reversibility of inhibitory activity is an important feature for physiological applications of inhibitors. Folimycin and bafilomycin Al have a drawback in this sense as their inhibitory action is not readily reversible. One goal of the present study is to demonstrate that the action of destruxin B can be reversed in a short time by washing it out. destruxin B inactivation. These results indicate that inhibition by destruxin B is far more readily reversible by washout relative to that of folimycin or bafilomycin Al.
Discussion
The acidification of intracellular compartments is pivotal in rather diverse aspects of cell physiology (2, 3) . In order to better understand the importance of an acidic pH in the lumina] space of organelles, many kinds of chemical inhibitors have been used. Since V-ATPase regulates this acidification, it is reasonable to assume that inhibitors of V-ATPase might benefit research concerned with these aspects of cell physiology. It was only recently, however, that specific inhibitors were discovered. Bafilomycins, 16-membered macrolide antibiotics, were the first to be characterized as specific inhibitors of V-ATPase, followed by concanamycins, 18-membered macrolides structurally related to the bafilomycins. Their usefulness has been proven through their application in many studies (13-18 and refs. therein).
One drawback of these macrolide antibiotics is that their action is not readily reversible. This may be due partly to the fact that they are highly lipophilic in nature and, as reported recently for bafilomycin Ci, appear to binds to the proteolipid subunit of the V-ATPase complex (19) .
This drawback can be overcome by the discovery of novel inhibitors such as destruxin B described in this paper. Destruxin B specifically inhibits V-ATPase, among examined ATPases, similar to the specificity of folimycin and bafilomycin Al (Fig. 1) . In contrast to the action of folimycin and bafilomycin Al, the action of destruxin B is nearly completely reversed within 30 min after washing as determined by the accumulation of acridine orange in intracellular organelles (Fig. 4) .
The dose-response of cell growth inhibition by destruxin B , as well as that of folimycin and bafilomycin Al, is in good agreement with that of V-ATPase inhibition in vitro and acidification of organelles at the cellular level (Fig. 3) . This suggests that disruption of intracellular organelle acidification is the major cause of arrested cell growth, but it does not rule out other possible targets of action. A definitive clarification of the specificity of destruxin B action awaits for further studies, but its novel action should prove to be a useful probe in future studies on VATPase and the function of acidification in intracellular organelles.
